LEADER 04291nam 2200673 a 450 001 9911019170303321 005 20200520144314.0 010 $a9786613679222 010 $a9781280768453 010 $a1280768452 010 $a9780470718896 010 $a0470718897 010 $a9780470716328 010 $a0470716320 035 $a(CKB)1000000000687590 035 $a(EBL)703735 035 $a(SSID)ssj0000715207 035 $a(PQKBManifestationID)11426674 035 $a(PQKBTitleCode)TC0000715207 035 $a(PQKBWorkID)10700235 035 $a(PQKB)10536263 035 $a(MiAaPQ)EBC703735 035 $a(OCoLC)264624750 035 $a(Perlego)2761964 035 $a(EXLCZ)991000000000687590 100 $a20120305d1954 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation symposium on hypertension $ehumoral and neurogenic factors /$feditors for the Ciba Foundation, G.E.W. Wolstenholme and Margaret P. Cameron ; assisted by Joan Etherington 210 $aLondon $cJ. & A. Churchill Ltd.$d1954 215 $a1 online resource (314 p.) 225 1 $aNovartis Foundation Symposia ;$vv.877 300 $a"With 73 illustrations." 311 08$a9780470722329 311 08$a0470722320 320 $aIncludes bibliographical references and indexes. 327 $aHYPERTENSION Humoral and Neurogenic Factors; CONTENTS; Chairman's opening remarks; Neural and humoral control of blood vessels; Discussion; Some new aspects of reflex blood pressure regulation and hypertension; Discussion; Hypertensive disease without hypertension; Discussion; Internal secretion of the arterial wall in blood pressure regulation; Discussion; Drugs antagonistic to 5-hydroxytryptamine; Quantitative estimation of 5-hydroxytryptamine in gastro-intestinal mucosa, spleen and blood of vertebrates; Discussion; Chemical screening methods for the diagnosis of phaeochromocytoma 327 $aDiscussionPersistence of hypertension after removal of phaeochromocytoma, where excretion of adrenaline and noradrenaline is normal; Discussion; Experimental studies on the pathogenesis and nature of hypertensive cardiovascular disease; Discussion; Experiments on the role of vasoconstrictor substances in the mechanism of renal hypertension in dogs; Discussion; The relation of the sustained pressor principle to renin; Discussion; The role of the kidney in the mechanism of experimental hypertension; Discussion 327 $aThe effect of partial renal corticectomy on the kidneys of normal and hypertensive animalsDiscussion; The use of ganglion blocking agents in relation to neurogenic factors in hypertension; Discussion; Lessons from hexamethonium studies in malignant hypertension; Discussion; Catechol amine excretion in urine in cases of hypertension; The relationship between sodium, arterial hypertension and the adrenal glands; Discussion; The study of adrenal insufficiency in hypertensive patients submitted to bilateral syrnpathectomy and unilateral adrenalectomy; Discussion 327 $aWater and electrolytes in experimental hypertensionThe distribution of fluid and electrolytes in experimental hypertension; Discussion; The importance of sodium chloride and its ions in the production and treatment of hypertension; Discussion; Chairman's closing remarks 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aNovartis Foundation Symposia 606 $aHypertension$vCongresses 615 0$aHypertension 676 $a616.1/32 676 $a616.132 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 701 $aCameron$b Margaret P$0290945 712 02$aCiba Foundation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019170303321 996 $aCiba Foundation symposium on hypertension$93004832 997 $aUNINA